Complete endoscopic remission is not only associated with higher mucosal concentrations of 5-aminosalicylic acid but also with N-acetyl-5-aminosalicylic acid in patients with ulcerative colitis

被引：0
|
作者：
Fukuda, T. [1 ]
Naganuma, M. [1 ]
Takabayashi, K. [2 ]
Hagihara, Y. [1 ]
Tanemoto, S. [1 ]
Nomura, E. [1 ]
Yoshimatsu, Y. [1 ]
Sugimoto, S. [1 ]
Nanki, K. [1 ]
Mizuno, S. [1 ]
Mikami, Y. [1 ]
Fukuhara, K. [3 ]
Suzino, T. [1 ]
Mutaguchi, M. [2 ]
Inoue, N. [3 ]
Ogata, H. [2 ]
Iwao, Y. [3 ]
Kanai, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan
[2] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan
[3] Keio Univ, Sch Med, Ctr Prevent Med, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P630
引用
收藏
页码：S522 / S523
页数：2
相关论文
共 50 条
  • [21] Predictive Factors for Relapse of Ulcerative Colitis in Patients With Remission After Reducing 5-Aminosalicylic Acid
    Toyokawa, Yuki
    Uchiyama, Kazuhiko
    Hotta, Yuma
    Tanaka, Makoto
    Dohi, Osamu
    Okayama, Tetsuya
    Yoshida, Naohisa
    Katada, Kazuhiro
    Kamada, Kazuhiro
    Ishikawa, Takeshi
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Naito, Yuji
    Itoh, Yoshito
    GASTROENTEROLOGY, 2016, 150 (04) : S446 - S446
  • [22] Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
    Lee, Jin
    Jee, Sam Ryong
    Kim, Hyung Wook
    Baek, Dong Hoon
    Song, Geun Am
    Moon, Won
    Park, Seun Ja
    Kim, Hyun Jin
    Lee, Jong Hoon
    Park, Jong Ha
    Kim, Tae Oh
    PLOS ONE, 2019, 14 (03):
  • [23] Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
    Le Berre, Catherine
    Roda, Giulia
    Protic, Marijana Nedeljkovic
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 363 - 378
  • [24] TREATMENT OF ULCERATIVE-COLITIS WITH 5-AMINOSALICYLIC ACID - RESPONSE
    SUTHERLAND, LR
    MAY, G
    SHAFFER, E
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 859 - 859
  • [25] MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS WITH ORAL PREPARATION OF 5-AMINOSALICYLIC ACID - REPLY
    DEW, MJ
    BRITISH MEDICAL JOURNAL, 1982, 285 (6351): : 1355 - 1355
  • [26] 5-AMINOSALICYLIC ACID SUPPOSITORIES IN THE MANAGEMENT OF ULCERATIVE-COLITIS
    CAMPIERI, M
    GIONCHETTI, P
    BELLUZZI, A
    BRIGNOLA, C
    TORRESAN, F
    TAMPIERI, M
    IANNONE, P
    MIGLIOLI, M
    BARBARA, L
    DISEASES OF THE COLON & RECTUM, 1989, 32 (05) : 398 - 399
  • [27] Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis
    Kane, S. V.
    Accortt, N. A.
    Magowan, S.
    Brixner, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (08) : 855 - 862
  • [28] ORAL 5-AMINOSALICYLIC ACID IN THE TREATMENT OF ULCERATIVE-COLITIS
    HABAL, FM
    GREENBERG, GR
    GASTROENTEROLOGY, 1985, 88 (05) : 1409 - 1409
  • [29] Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
    Lee, Hye Young
    Baek, Dong Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 83 (05): : 197 - 199
  • [30] What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
    Riley, SA
    GUT, 1998, 42 (06) : 761 - 763
12345